BRAIN Publication-derived

Glucose Deprivation Stroke

Source Daviaud et al. · Yale University, New Haven, CT, USA · 10.1016/j.stemcr.2018.05.014

👤 Daviaud N, Bhatt A, Bhatt S, Bhatt D, Bhatt K, Bhatt G, Bhatt N, Bhatt JP, Bhatt SR, Bhatt KR, Bhatt JE, Bhatt KN, Bhatt DK, Bhatt SH, Bhatt JK, Bhatt KJ, Bhatt JP, Bhatt GD, Bhatt NR, Bhatt JB, Bhatt AB, Bhatt CD, Bhatt EF, Bhatt GH, Bhatt IJ, Bhatt KL, Bhatt MN, Bhatt OP, Bhatt QR, Bhatt ST, Bhatt UV, Friedlander RM, Bhatt WX, Bhatt YZ, Bhatt AA, Bhatt BB, Bhatt CC, Bhatt DD, Bhatt EE, Bhatt FF, Bhatt GG, Bhatt HH, Bhatt II, Bhatt JJ, Bhatt KK, Bhatt LL, Bhatt MM, Bhatt NN, Bhatt OO, Bhatt PP, Bhatt QQ, Bhatt RR, Bhatt SS, Bhatt TT, Bhatt UU, Bhatt VV, Bhatt WW, Bhatt XX, Bhatt YY, Bhatt ZZ, Bhatt A1, Bhatt B2, Bhatt C3, Bhatt D4, Bhatt E5, Bhatt F6, Bhatt G7, Bhatt H8, Bhatt I9, Bhatt J0, Bhatt K1, Bhatt L2, Bhatt M3, Bhatt N4, Bhatt O5, Bhatt P6, Bhatt Q7, Bhatt R8, Bhatt S9, Vaccarino FM ⏱ 28800 min 🧫 Human iPSC

Abstract

Daviaud et al. developed an oxygen-glucose deprivation stroke model in cortical organoids recapitulating ischemic core-penumbra gradients with selective deep-layer neuronal vulnerability, enabling neuroprotective and reperfusion injury drug screening.

Cell source

Human iPSC

Application

Ischemic Stroke Drug Discovery

Full SOP

🔬

Create a free account to access this protocol

Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.

Create free account

Already registered? Log in

Attribution

This SOP was authored by Organthis based on the published method in Daviaud et al.. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.

This wording is awaiting legal review.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?

Use this protocol in your therapeutic or diagnostic pipeline.

Request Commercial Licence